ISSN: 1555-4309

Journal Home

Contrast Media and Molecular Imaging - Unclaimed

Hindawi Limited United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Contrast Media and Molecular Imaging is a journal indexed in SJR in Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging with an H index of 62. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1440 €. The scope of the journal is focused on molecular imaging, cellular imaging, contrast media, magnetic resonance imaging. It has a best quartile of -. It is published in English.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) Radiology, Nuclear Medicine and Imaging

Price

1440 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0

SJR Impact factor

62

H Index

9

Total Docs (Last Year)

768

Total Docs (3 years)

78

Total Refs

1023

Total Cites (3 years)

766

Citable Docs (3 years)

1.27

Cites/Doc (2 years)

8.67

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Disease Markers -
Computational Intelligence and Neuroscience -
Annals of Medicine and Surgery -
World Journal of Clinical Cases -
Advances in Anatomy Embryology and Cell Biology -

Compare this journals

Aims and Scope

Molecular imaging Cellular imaging Contrast media Magnetic resonance imaging

Best articles by citations

Regional quantitative analysis of small animal myocardial sympathetic innervation and initial application in streptozotocin induced diabetes

Optoacoustic imaging enabled biodistribution study of cationic polymeric biodegradable nanoparticles

Assessment of real-time myocardial uptake and enzymatic conversion of hyperpolarized [1-13C]pyruvate in pigs using slice selective magnetic resonance spectroscopy

A new method for the aqueous functionalization of superparamagnetic Fe2O3nanoparticles

Application of Image Processing Techniques in Molecular Imaging of Cancer

CMR 2005: 1.01: The hepatobiliary excretion of Gd-BOPTA does not interfere with the clearance of other drugs

CMR 2005: 1.02: Extraction rate of SPIO by the normal and gadolinium chloride-treated liver

CMR 2005: 1.03: Analysis of hepatic uptake of anionic magnetic nanoparticles

CMR 2005: 1.04: Comparison of VSOP-C184, gadopentetate dimeglumine and ferucarbotran in T1-weighted dynamic and T2-weighted late MRI of focal liver lesions in rabbits

Imaging of angiogenesis using Cadence‚Ñ¢ contrast pulse sequencing and targeted contrast agents

CMR 2005: 1.05: Does dual-contrast MRI of the liver improve the detection of focal liver lesions? On-site results of a prospective multicenter study

CMR 2005: 1.06: Comparison of liver metastasis detectability from colorectal cancer between SPIO-MRI and diffusion-weighted imaging: how and when should SPIO-MRI be applied?

SHOW MORE ARTICLES

CMR 2005: 2.01: High-field MRA with iron oxide blood-pool contrast agents: field strength effects on vascular contrast enhancement in rabbits at 1.5 and 3.0 T

Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy

CMR 2005: 2.02: Interventional double-contrast MR angiography: intra-arterial injections of SPIO particles SHU 555 C (Resovist¬Æ) in combination with trueFISP imaging

CMR 2005: 2.03: VSOP-C184 as contrast agent for MRI of atherosclerotic plaques: experimental results in rabbits

CMR 2005: 2.04: MRI of cerebral ischemia with ultra-small superparamagnetic particles of iron oxide in mice

CMR 2005: 2.05: Use of magnetic nanoparticles as intracellular agents for hyperthermia

CMR 2005: 2.06: Ferumoxtran-10 enhanced MR imaging in detection of metastases outside the normal surgical area in prostate cancer

CMR 2005: 3.01: MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctylmannose conjugate (Gadofluorine M), a novel protein-avid contrast agent

CMR 2005: 3.02: The stromal mechanism: an inherent link between necrosis-avid contrast agents and photodynamic therapy

Optical probes and the applications in multimodality imaging

Nanoparticle-stabilized microbubbles for multimodal imaging and drug delivery

CMR 2005: 3.03: New RGD peptide-based molecular imaging agents for detection of angiogenesis